|  | Cross-validation | |||
---|---|---|---|---|---|
Trait†| Subpopulation* | Pedigree (CV2-A) | Markers (CV2-RR) | Markers and pedigree (CV2-RRA) | Relative efficiency markers/pedigree (%) |
ADEN | BG1 | 0.57 | 0.59 | 0.62 | 104 |
 | BG1 → BG2 | 0.10 | 0.10 | 0.19 | – |
 | S1 | 0.71 | 0.63 | 0.69 | 89 |
 | S1 → S2 | 0.59 | 0.53 | 0.57 | 90 |
AMFA | BG1 | 0.55 | 0.36 | 0.47 | 65 |
 | BG1 → BG2 | 0.13 | 0.04 | 0.05 | – |
 | S1 | 0.62 | 0.52 | 0.61 | 84 |
 | S1 → S2 | 0.52 | 0.41 | 0.50 | 79 |
HT17 | BG1 | 0.44 | 0.33 | 0.42 | 75 |
 | BG1 → BG2 | −0.01 | −0.01 | −0.01 | – |
 | S1 | 0.66 | 0.55 | 0.64 | 83 |
 | S1 → S2 | 0.33 | 0.22 | 0.29 | 67 |
DBH17 | BG1 | 0.30 | 0.29 | 0.34 | 97 |
 | BG1 → BG2 | 0.13 | −0.06 | −0.07 | – |
 | S1 | 0.53 | 0.48 | 0.53 | 91 |
 | S1 → S2 | 0.23 | 0.15 | 0.20 | 65 |
MSE‡ |  | 0.081 | 0.075 | 0.074 | – |